Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Syringaresinol Protects against Type 1 Diabetic Cardiomyopathy by Alleviating Inflammation Responses, Cardiac Fibrosis, and Oxidative Stress
Guangru Li, Lei Yang, Lifeng Feng, et al.
Molecular Nutrition & Food Research (2020) Vol. 64, Iss. 18
Closed Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Diabetic vascular diseases: molecular mechanisms and therapeutic strategies
Yiwen Li, Yanfei Liu, Shiwei Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 257
Diabetic cardiomyopathy: Early diagnostic biomarkers, pathogenetic mechanisms, and therapeutic interventions
Jin-Ling Huo, Qi Feng, Shaokang Pan, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 65
The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review
Wencan Li, Xiang Liu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 26
Nrf2 signaling in diabetic nephropathy, cardiomyopathy and neuropathy: Therapeutic targeting, challenges and future prospective
Mehrdad Hashemi, Mohammad Arad Zandieh, Setayesh Ziaolhagh, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1869, Iss. 5, pp. 166714-166714
Open Access | Times Cited: 32
Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway
Guangru Li, Chang Liu, Lei Yang, et al.
Cell Biology and Toxicology (2023) Vol. 39, Iss. 3, pp. 621-639
Closed Access | Times Cited: 23
Melatonin attenuates diabetic cardiomyopathy by increasing autophagy of cardiomyocytes via regulation of VEGF-B/GRP78/PERK signaling pathway
Shengzheng Zhang, Wencong Tian, Xianxian Duan, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
A Narrative Review of Diabetic Macroangiopathy: From Molecular Mechanism to Therapeutic Approaches
Jiacheng Yin, Xiaoxu Fu, Yue Luo, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 3, pp. 585-609
Open Access | Times Cited: 9
Syringaresinol attenuates sepsis-induced cardiac dysfunction by inhibiting inflammation and pyroptosis in mice
Ao Wei, jingjing Liu, Dihua Li, et al.
European Journal of Pharmacology (2021) Vol. 913, pp. 174644-174644
Closed Access | Times Cited: 53
Ferroptosis and Its Potential Role in Metabolic Diseases: A Curse or Revitalization?
Jia-Yue Duan, Xiao Lin, Feng Xu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 52
Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling
Jiale An, Lifeng Feng, Jiling Ren, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 51
Mechanisms and Therapeutic Prospects of Diabetic Cardiomyopathy Through the Inflammatory Response
Namrita Kaur, Yingshu Guan, Rida Raja, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 48
Lignans as Pharmacological Agents in Disorders Related to Oxidative Stress and Inflammation: Chemical Synthesis Approaches and Biological Activities
Dmitry I. Osmakov, Aleksandr P. Kalinovskii, Olga A. Belozerova, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6031-6031
Open Access | Times Cited: 38
Potential clinical biomarkers and perspectives in diabetic cardiomyopathy
Jianxin Deng, Yan Fang, Jinglun Tian, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 22
Antioxidant Activity of Panax ginseng to Regulate ROS in Various Chronic Diseases
Md. Niaj Morshed, Jong Chan Ahn, Ramya Mathiyalagan, et al.
Applied Sciences (2023) Vol. 13, Iss. 5, pp. 2893-2893
Open Access | Times Cited: 20
What is the impact of ferroptosis on diabetic cardiomyopathy: a systematic review
Xiaokun Lou, Yuanyuan Zhang, Junfeng Guo, et al.
Heart Failure Reviews (2023) Vol. 29, Iss. 1, pp. 1-11
Closed Access | Times Cited: 14
Syringaresinol Alleviates Early Diabetic Retinopathy by Downregulating HIF‐1α/VEGF via Activating Nrf2 Antioxidant Pathway
Chang Liu, Tianwei Cheng, Yufei Wang, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 5
The role and therapeutic potential of macrophages in the pathogenesis of diabetic cardiomyopathy
Shan Zhang, Xueying Zhu, Yupeng Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
(–)-Syringaresinol attenuates ulcerative colitis by improving intestinal epithelial barrier function and inhibiting inflammatory responses
Yunhe Liu, Junzhe Wu, Luying Tan, et al.
Phytomedicine (2023) Vol. 124, pp. 155292-155292
Closed Access | Times Cited: 11
Syringaresinol Resisted Sepsis-Induced Acute Lung Injury by Suppressing Pyroptosis Via the Oestrogen Receptor-β Signalling Pathway
Yuzhen Zhuo, Lei Yang, Dihua Li, et al.
Inflammation (2021) Vol. 45, Iss. 2, pp. 824-837
Closed Access | Times Cited: 25
Inhibition of high glucose-induced cardiac fibroblast activation: an effective treatment for diabetic cardiomyopathy using Chinese herbal medicine
Bin Wan, Jing Hu, Yue Luo, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Non-coding RNA as a key regulator and novel target of apoptosis in diabetic cardiomyopathy: Current status and future prospects
Yicheng Liu, Jie Yuan, Yuhang Zhang, et al.
Cellular Signalling (2025) Vol. 128, pp. 111632-111632
Closed Access
Exploring the protective mechanisms of syringaresinol against myocardial infarction by experimental validation and network pharmacology
Lifeng Feng, Ruopeng Sun, Hanmo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 4, pp. 167728-167728
Closed Access
A comprehensive review on diabetic cardiomyopathy (DCM): histological spectrum, diagnosis, pathogenesis, and management with conventional treatments and natural compounds
Ahmed R. Abdullah, Mahmoud A. Seliem, Emad Gamil Khidr, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Research progress on the role and inhibitors of Keap1 signaling pathway in inflammation
Chao Ding, Ying Wu, Chaochao Zhan, et al.
International Immunopharmacology (2024) Vol. 141, pp. 112853-112853
Closed Access | Times Cited: 3
Syringaresinol alleviates IgG immune complex induced acute lung injury via activating PPARγ and suppressing pyroptosis
Sijia Zhang, Lei Yang, Dongsheng Hu, et al.
International Immunopharmacology (2023) Vol. 124, pp. 111071-111071
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top